CPT Test code: 82977
|Serum (preferred) or plasma
|Red-top tube, gel-barrier tube, green-top (heparin) tube, or lavender-top (EDTA) tube
|Separate serum or plasma from cells within 45 minutes of collection.
|Maintain specimen at room temperature.
|The patient should fast for eight hours prior to collection of the specimen. Since there are false elevations in patients on phenytoin and phenobarbital, such patients would be better served with orders for one of the alternate tests − leucine aminopeptidase (LAP) or 5′ nucleotidase.
|Causes for Rejection:
|Gross hemolysis; improper labeling; gross lipemia
|• Male: 0-65 IU/L• Female: 0-60 IU/L
|A biliary enzyme that is especially useful in the diagnosis of obstructive jaundice, intrahepatic cholestasis, and pancreatitis.1 GT is more responsive to biliary obstruction than are aspartate aminotransferase (AST) (SGOT) and alanine aminotransferase (ALT) (SGPT).Increased in hepatoma and carcinoma of pancreas. Useful in diagnosis of metastatic carcinoma in the liver. Increasing levels in carcinoma patients relate to tumor progression, and diminishing levels to response to treatment.2 CEA, alkaline phosphatase, and GT used together are useful markers for hepatic metastasis from breast and colon primaries. GT is elevated in some instances of seminoma.
Useful in diagnosis of chronic alcoholic liver disease, but some heavy drinkers do not have GT increases. Serial determinations of serum GT, AST, and ALT levels can distinguish recovering alcoholics who resume drinking from those who remain abstinent.3,4 Increase in body mass is positively correlated with increased GT levels.5 With MCV of red cells, GT is useful as a test for alcoholism.
GT is the test for cholestasis during or immediately following pregnancy. Commonly elevated in cirrhosis and hepatitis. The transaminases, AST and ALT rise higher in acute viral hepatitis; these tests with GT and other parameters are best used together in work-up of liver disease.
Increased in systemic lupus erythematosus.2 Very high levels are common in primary biliary cirrhosis. High GT is found in infants with biliary atresia. It is increased with hyperthyroidism and decreased in those with hypothyroidism.6 GT is comparable in many ways to two other biliary tests, LAP and 5′ nucleotidase. In some cases, five tests (including alkaline phosphatase and bilirubin) are necessary to evaluate the biliary tract. GT usually is the most sensitive.
In ascitic fluid, very high GT is said to suggest hepatoma as opposed to cirrhosis or liver metastases.
|Acetaminophen toxicity has been reported to cause an in vivo increase. The combination of high alkaline phosphatase and normal GT does not rule out liver disease completely. Activity is not significantly increased in sera of patients with lymphoma (unless there is hepatic involvement by the lymphoma). Baden et al concluded that as a preoperative test for metastasis with colorectal carcinoma, GT is unsatisfactory.7 As part of a evaluation for carcinoma patients, 19% of GT results from patients with progressive disease were not abnormal, and 4% of values from patients without evidence of tumor were high.2
|GT is helpful to work up elevated alkaline phosphatase values. GT is a biliary excretory enzyme which is more specific for hepatic disease than is alkaline phosphatase. It is normal in most instances of renal failure.8 GT has no origin in bone or placenta, unlike alkaline phosphatase, and age beyond infancy does not influence GT levels. Activity of GT is highest in obstructive liver disease. It is commonly elevated in patients with infectious mononucleosis. When GT and alkaline phosphatase are both high, but one is disproportionately elevated, suspect the possibility of drug-induced cholestasis (including alcoholism if it is GT which is much higher). GT, postprandial glucose, and triglyceride bear some correlation in certain groups of patients, including alcoholism and diabetes mellitus. Treatment of hypertriglyceridemia may also lead to decreased GT. GT is normal in normal children, adolescents, and in pregnant women. Unlike AST, it is not elevated in skeletal muscle disease.